Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HLX26 Plus Serplulimab in mCRC
NCT05584137Phase 2Terminated
- Sponsor
- Henlius
- Start
- Jun 2023
- Primary completion
- Dec 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of hlx26 in colorectal cancer (CRC), sponsored by Henlius. Started Jun 2023; status: terminated.
02
Drugs
hlx26
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05584137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05584137.